A new report from Pitchbook suggests we’re in for a period of more sustainable investing, with VC firms continuing to create ...

Biopharmaceutical stocks are in focus on Monday after Bristol-Myers Squibb (BMY) announced an $11 billion partnership with ...

After a back and forth with two potential buyers, bluebird bio has completed its sale to funds managed by global investment ...

China is now setting the pace in life sciences R&D, conducting more clinical trials than the U.S. and licensing new ...